SCHEMBL6162263

SCHEMBL6162263

CCc1ccc(Oc2ccc(CN)cn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 2/20 0.48
KDM4E B2RXH2 3/20 0.43
POLB P06746 1/20 0.43
ST14 Q9Y5Y6 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LOXL2 Q9Y4K0 3/20 0.41
EGLN1 Q9GZT9 1/20 0.40
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
OPRK1 P41145 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 1/20 0.40
LOX P28300 1/20 0.40
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ACACB O00763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20771833 0.87 MAOB (0.51) RAB9ANPC1KDM4EPOLBST14
SCHEMBL8541822 0.87 KDM4E (0.58) RAB9ASMN1; SMN2NPC1KDM4EPOLB
SCHEMBL4380974 0.83 MEN1 (0.63) KDM4EST14MEN1KMT2ALOXL2
SCHEMBL30744447 0.83 MEN1 (0.63) KDM4EST14MEN1KMT2ALOXL2
SCHEMBL9045204 0.83 MAOB (0.53) KDM4EPOLBST14MEN1KMT2A
SCHEMBL6160873 0.83 LOXL2 (0.58) LOXL2OPRM1OPRD1OPRK1ALDH1A1
SCHEMBL19362952 0.81 KDM4E (0.59) RAB9ASMN1; SMN2NPC1KDM4EPOLB
Hydrochloric Acid SCHEMBL5010402 0.81 LOXL2 (0.59) LOXL2OPRM1OPRD1OPRK1ALDH1A1
SCHEMBL14349927 0.80 P2RX3 (0.48) SMN1; SMN2KDM4EL3MBTL1MAPTTDP1
SCHEMBL12967186 0.80 MEN1 (0.58) RAB9ASMN1; SMN2NPC1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050165064-A1 Novel thiol derivative, process for producing the same and use thereof TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. 2005-07-28 US disclosed
EP-1500658-A1 NOVEL THIOL DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050165064-A1 Novel thiol derivative, process for producing the same and use thereof TST, QSOX1, MMP1 RAB9A 3296/4885SMN1; SMN2 3640/4885NPC1 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.